Live-Cell Therapy: A Startling New Development for Curing Disease, Dr.Abhay Kumar Pati

Oct. 3, 2010 - PRLog -- In the fall of 1987, word began to circulate in reports from Sweden and Mexico that human fetal tissues (usually from the adrenals), when implanted directly into the brains of a group of patients with Parkinson’s disease, had caused a significant reduction in symptoms. Earlier, U.S. medical research had found that human embryonic tissues injected into animals would stimulate the growth of new cells and in various conditions could bring a decrease in the symptoms. The reports of beneficial results when this approach was used on people aroused considerable interest and discussion in medical circles.
New phrases were created to describe several similar procedures: tissue transfer therapy, tissue transplantation therapy, etc. We like the term “live cell therapy,” since it is fully descriptive of the techniques we are following and has the advantage of brevity. Whichever name is chosen, these therapies are similar in theory and are simply expressions of “live-cell” or “cellular” therapy— a form of treatment which was pioneered a half-century ago in Europe and became widely recognized throughout most of the world, while it was blissfully ignored in the United States. The success with Parkinson’s disease, primarily by Mexico City neurosurgeon Ignacio Navarro Madrazo, M.D., may bring a greater acceptance of live-cell therapy by U.S. doctors.
We should note that Parkinson’s is only one of many conditions that have responded to the form of live-cell therapy advanced by the late Paul Niehans, M.D., of Switzerland; i.e. the intramuscular of subdermal injection salt solution. The term “fresh” is used so as to distinguish the Niehans technique from the assembly-line administration of commercial freeze-dried cells (products made available on the world market, mostly from West Germany). It should perhaps be pointed out that the major German manufacturers have been barred by German authorities for one year from distributing such products, following the death of a woman athlete apparently from over-administration of these commercial materials.
Direct Experience with Live-cell Therapy
The primary author of this article, Dr. W. Kuhnau, has had some 30 years of experience with live-cell therapy, having treated approximately 20,000 patients with this technique. Using a safe, well-tested therapeutic approach, he has not found any toxic, reactions.
alternative At the Americal Biologics-Mexico S.A. Medical Center, and at the Bradford Research Institute-Mexico, live-cell therapy has been employed either as primary or adjunctive therapy on thousands of patients with various types of complaints, during the past ten years... commencing in late 1979. The material used was embryonic tissue from calves, and it has been found to be remarkably successful for numerous difficult conditions, ranging from childhood retardation problems to multiple sclerosis, and even in cases of advanced cancer.
Among the many impressive results seen at the Mexican facilities has been the normalization of liver enzyme values (in an organ that had been diseased by infection in 1950) by a single injection of material from shark liver, as well as dramatic responses in a wide range of childhood and infantile dysfunctions.
Cellular injections are usually given as a part, either central or adjunctive, of what the B.R.I. calls “individualized, integrated metabolic programs”... which usually call for vitamins, minerals, enzymes, amino acids, and various antioxidant and oxidative substances.
Live-cell therapy works because embryonic cells from unborn animals (such as embryonic calves in the second or third month of pregnancy) are immunologically inactive and thus are not rejected as non-self by the immune system of the person receiving the injection.
The effect of this therapy is to harmonize hormones: balance the intricate hormone-producing and feedback mechanisms of the endocrine system.
Historical Background
The idea of using animal and even human tissue for rejuvenation and for treatment of disease is as old as mankind. The most ancient finding in this area was in China, close to Beijing, where skulls from 1.5 million years B.C. were found, which show clearly that the brains of the deceased were eaten by their descendants — probably for religious reasons. There have also been reports from ancient India and Egypt concerning the use of placenta for rejuvenation in the second millennium B.C., and also from Thailand. However, the most important support for the concept came from the famous medieval Swiss physician, Paracelsus, who maintained that “heart heals heart, kidney heals kidney, liver heals liver,” etc.
In the late 19th century, Dr. Alexis Crroll cultivated heart cells from chickens, and found that when two hearts with different beats were joined, they beat in unison.
In 1912, Kuttner of Germany published his research showing why entire organs should not be transplanted (as many were attempting to do) because a transplanted organ with no connection to blood vessels destroys itself through the process of autolysis. Kuttner recommended that the organ be cut into small pieces, ground in a mortar, and mixed in a solution before being injected into a patient. He called this procedure “injection transplantation”. Unfortunately Dr. Kuttner’s work was not recognized or accepted until many years later, when other journals published similar reports.
Continuing with scientific investigation in this field, German researchers Landsberger and Lettre injected cellular material from radioactive rats into the bodies of other animals. Tracing it with a Geiger counter, they found that the material was brought through hostal macrophages to the tissues where it is needed; that is, liver cells go to the liver, heart cells go to the heart, etc.
Later, Gibson from Mount Sinai Hospital in New York injected embryonic cells from the brains of normal mice into the brains of hereditarily infertile mice — rendering them fertile.
American Nobel Prize winner Guillemain determined the average daily production of the hormone ACTH in a culture of pituitary cells. He then added embryonic cells from the hypothalamus glands of other species, and found that this caused two to three times as much ACTH to be produced.
In Rochester, New York, Gash transplanted embryonic cells into the brains of monkeys, which were still alive and healthy six and 12 months later. These cells apparently stimulated the growth of new nerve communications and glia cells. Dr. Gash was able to discover the source of this activity, and he called the substance “neural growth factor.”
Rutenstroth of Germany implanted an extract from Peyer’s patches, and found that new liver tissue was produced in the host. He also found that embryonic liver tissue was produced in the host. He also found that embryonic liver cells, regardless of the species from which they were taken, were able to stimulate the growth of new liver tissue in a host. He called this the “liver growth hepatopoetic factor.” The procedure has become fairly well known since Dr. Rutenstroth’s original work, and other researchers have proven that regardless of the species from which they have come, the cells are able to stimulate growth in certain organs.

# # #

Best Nutrition Products, Inc.Hayward, California, USA and Biotechayur, Odisha, India manufacture a large number of vitamins, minerals, Chinese and Ayurvedic herbal and nutritional supplements and raw materials of standardized herbal extracts.